Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$81 | -$60 | -$91 | -$108 |
| Dep. & Amort. | $14 | $16 | $15 | $16 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $18 | $22 | $20 | $21 |
| Change in WC | $14 | -$23 | -$12 | $2 |
| Other Non-Cash | $3 | $5 | $15 | $27 |
| Operating Cash Flow | -$32 | -$40 | -$52 | -$42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$8 | -$14 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$82 | -$129 | -$191 | $0 |
| Inv. Sales/Matur. | $9 | $65 | $0 | $1 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$73 | -$64 | -$199 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $0 | $0 | $0 |
| Financing Cash Flow | $10 | -$0 | -$0 | -$0 |
| Forex Effect | $0 | -$2 | $0 | -$0 |
| Net Chg. in Cash | -$94 | -$106 | -$250 | -$56 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251 | $320 | $606 | $662 |
| End Cash | $157 | $215 | $355 | $606 |
| Free Cash Flow | -$32 | -$40 | -$59 | -$56 |